LAMA add‐on vs long‐acting beta2‐agonists (LABA) add‐on
FEV1 · adults with asthma not well controlled on ICS
1 finding from 1 review
- Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting… 2015 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 1745 participantsModerate